Jun 30, 2018

Cogent Biosciences Q2 2018 Earnings Report

Total Revenue
$1.67M
Previous year: $2.08M
-19.9%
EPS
-$0.31
Previous year: -$0.793
-60.9%
Gross Profit
$1.67M
Previous year: $2.08M
-19.9%
Cash and Equivalents
$46.7M
Free Cash Flow
-$8.3M
Total Assets
$103M

Cogent Biosciences

Cogent Biosciences